E25

2.44%

20.0¢ element 25 limited

Ann: Trading Halt, page-24

First 24 Last

Share
Profile

Follow
srood

2,748 Posts.

947

15/11/22

11:17

Post #: 64777814
Share

Originally posted by suzywongs: ↑

E25 is raising $30 million at $1.12 per share (stock closed at $1.435) to accelerate the planning and construction of a battery grade manganese plant likely to be built in Louisiana in the US using a combination of equity and debt contributions from (1) on-shore US manufacturers (not necessarily US manufacturers but also foreign manufacturers producing in US plants) of electric vehicles and (2) cathode manufacturers.

E25 may also qualify for further funding by US Department of Energy released as part of the Biden Administration’s Bipartisan Infrastructure Law to expand domestic manufacturing of batteries for electric vehicles and the electrical grid and for materials and components currently imported from other countries (ASX listed graphite producer Syrah Resources recently announced a US Department of Energy loan of US$102 million, and, separately, a US DOE grant of US$220 million, both to support the anode plant jointly developed by Syrah with its partner in Louisiana, USA).

E25 is close to announcing multiple agreements with OEM’s/cathode manufacturer(s) for the supply of E25’s battery grade manganese metal.

This process has had a fire put under it by the US Inflation Reduction Act, as Australia has a free trade agreement with the US and no other country supplying manganese has that essential requirement of the Act (see quote from E25 CEO Justin Brown below).

E25 is now the sole source of near-term battery grade manganese metal from outside China.
E25 believes it will have the lowest operating cost in the world including all of Chinese production.
Markets are beginning to realise that while it’s possible to choose to invest in more than 250 ASX or TSE listed companies in lithium, nickel and graphite, E25 is the only company that is investible for near-term manganese battery grade metal.
Investors are realising that manganese is by far the cheapest substitute available to replace other much more expensive battery metals in cathode production.

Expand

Thanks for posting. That puts a little perspective behind the raise and further validates completing from as at the present.

The sweeteners look to be substantial and close by.

E25 Price at posting: $1.44 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

ASX hits all time high out the gate on Friday trades following bullish US inflation data

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

There are more pages in this discussion • 29 more messages in this thread...

First 24 Last

Add E25 (ASX) to my watchlist

(20min delay)
Last 20.0¢		Change -0.005(2.44%)		Mkt cap ! $43.98M

Open	High	Low	Value	Volume
20.5¢	21.0¢	20.0¢	$13.12K	64.11K

Buyers (Bids)

No.	Vol.	Price($)
9	485354	20.0¢

Sellers (Offers)

Price($)	Vol.	No.
21.0¢	13766	2

View Market Depth

No.	Vol.	Price($)
9	485354	0.200
4	22828	0.190
1	2709	0.185
5	460000	0.180
2	30000	0.175

Price($)	Vol.	No.
0.210	13766	2
0.215	7400	2
0.225	24999	1
0.230	35000	1
0.235	5326	3

Last trade - 15.56pm 12/07/2024 (20 minute delay)

E25 (ASX) Chart

Ann: Trading Halt, page-24

Immutep reports strong response rate from immunotherapies treating carcinomas

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Nimy to raise $1.21M to explore 'newsy' WA targets

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Trading Halt, page-24

Top Stories

Immutep reports strong response rate from immunotherapies treating carcinomas

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Nimy to raise $1.21M to explore 'newsy' WA targets

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News